Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

CHINA-BIOTICS, INC (CHBT)

Income Statement Business | Product

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsMar-31-13Mar-31-12Mar-31-11Mar-31-10Mar-31-09Mar-31-08Mar-31-07Mar-31-06
   10-K10-K10-K10-K10-K10-K10-KS-1/A
Revenues:  
    Bulk additives  58.431.0      
    Retail products  17.427.9      
Total revenues   [+]3.10.8108.881.454.242.830.621.9
            Revenue growth   [+]277.2%-99.3%33.7%50.1%26.8%39.7%39.5% 
Cost of goods sold  31.526.238.924.116.2-12.3-8.9-6.4
Gross profit  -28.5-25.469.957.338.055.139.528.4
            Gross margin  -933.4%-3135.1%64.2%70.4%70.1%128.8%129.1%129.4%
Selling, general and administrative   [+]23.616.927.418.414.69.56.83.2
Research and development       2.2  
Other operating expenses  -68.4-45.86.73.61.621.317.813.0
EBITDA   [+]21.07.340.437.223.623.115.412.7
            EBITDA margin  689.9%905.1%37.2%45.8%43.5%54.1%50.4%57.9%
Depreciation  4.63.74.61.91.71.00.50.5
EBITA  16.43.635.835.321.822.114.912.2
            EBITA margin  538.2%451.0%32.9%43.4%40.3%51.7%48.8%55.6%
Amortization of intangibles  0.10.00.10.00.0   
EBIT   [+]16.33.635.735.321.822.114.912.2
            EBIT margin  534.8%444.9%32.8%43.4%40.2%51.7%48.8%55.6%
Interest expense, net   [+]-3.1-0.8-0.5-0.3-0.3-0.4-0.2 
Other income (expense), net   [+]0.51.514.6-12.13.1  0.1
Pre-tax income  19.25.645.923.425.122.515.112.3
Income taxes  3.82.89.07.85.24.94.23.9
            Tax rate  19.9%50.5%19.6%33.2%20.5%22.0%27.7%31.8%
Net income  0.00.00.00.00.017.510.98.4
            Net margin  0.0%0.0%0.0%0.0%0.0%41.0%35.6%38.1%
   
Basic EPS   [+]$0.00$0.00$0.00$0.00$0.00$1.03$0.64$4.90
Diluted EPS   [+]$0.00$0.00$0.00$0.00$0.00$1.03$0.64$4.90
   
Shares outstanding (basic)   [+]22.222.222.219.617.117.117.11.7
Shares outstanding (diluted)   [+]22.222.323.719.617.117.117.11.7
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy